‘I wouldn’t dare take these drugs . . . I just sell them’: how China supplies untested peptides to the west

Market Intelligence Analysis

AI-Powered
Why This Matters

China is supplying untested peptides to the West, driven by demand for weight-loss and other performance-enhancing drugs, raising concerns about safety and regulation.

Market Impact

Market impact analysis based on bearish sentiment with 80% confidence.

Sentiment
Bearish
AI Confidence
80%
Time Horizon
Short Term

Article Context

Note: This is a brief excerpt for context. Click below to read the full article on the original source.

The success of weight-loss drugs has driven demand for injectable compounds that claim to improve everything from sleep to skin

Continue Reading
Full article on Financial Times
Read Full Article
Original article published by Financial Times on January 29, 2026.
Analysis and insights provided by AnalystMarkets AI.